These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 20508203

  • 1. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ishii N, Matsumura T, Kinoshita H, Fukuda K, Motoshima H, Senokuchi T, Nakao S, Tsutsumi A, Kim-Mitsuyama S, Kawada T, Takeya M, Miyamura N, Nishikawa T, Araki E.
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
    [Abstract] [Full Text] [Related]

  • 2. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K, Rhainds D, Jossart C, Febbraio M, Marleau S, Ong H.
    Cardiovasc Res; 2009 Aug 01; 83(3):457-64. PubMed ID: 19377069
    [Abstract] [Full Text] [Related]

  • 3. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
    Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, Motoshima H, Murata Y, Kim-Mitsuyama S, Kawada T, Itabe H, Takeya M, Nishikawa T, Tsuruzoe K, Araki E.
    J Biol Chem; 2008 Apr 11; 283(15):9852-62. PubMed ID: 18208815
    [Abstract] [Full Text] [Related]

  • 4. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
    Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, Motoshima H, Taguchi T, Sonoda K, Kukidome D, Takuwa Y, Kawada T, Brownlee M, Nishikawa T, Araki E.
    Circ Res; 2007 May 25; 100(10):1442-51. PubMed ID: 17463321
    [Abstract] [Full Text] [Related]

  • 5. Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages.
    Matsumura T, Kinoshita H, Ishii N, Fukuda K, Motoshima H, Senokuchi T, Taketa K, Kawasaki S, Nishimaki-Mogami T, Kawada T, Nishikawa T, Araki E.
    Arterioscler Thromb Vasc Biol; 2011 Jun 25; 31(6):1268-75. PubMed ID: 21474824
    [Abstract] [Full Text] [Related]

  • 6. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Avallone R, Demers A, Rodrigue-Way A, Bujold K, Harb D, Anghel S, Wahli W, Marleau S, Ong H, Tremblay A.
    Mol Endocrinol; 2006 Dec 25; 20(12):3165-78. PubMed ID: 16959872
    [Abstract] [Full Text] [Related]

  • 7. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y, Yao S, Yan H, Hu L, Yu C, Gao F, Xi C, Li H, Ye Y, Wang Y.
    Cardiovasc Res; 2016 Oct 25; 112(1):502-14. PubMed ID: 27460841
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ, Zeng DY, Mai XY, Shang JY, Wu QQ, Yuan JN, Yu BX, Zhou P, Zhang FR, Liu YY, Lv XF, Liu J, Ou JS, Qian JS, Zhou JG.
    Arterioscler Thromb Vasc Biol; 2016 Apr 25; 36(4):618-28. PubMed ID: 26916730
    [Abstract] [Full Text] [Related]

  • 9. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S, Harb D, Bujold K, Avallone R, Iken K, Wang Y, Demers A, Sirois MG, Febbraio M, Silverstein RL, Tremblay A, Ong H.
    FASEB J; 2005 Nov 25; 19(13):1869-71. PubMed ID: 16123174
    [Abstract] [Full Text] [Related]

  • 10. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L, Li Z, Li Q, Guan H, Zhao S, Liu R, Wang R, Zhang J, Jia Y, Fan J, Wang N, Reddy JK, Shyy JY, Liu E.
    Arterioscler Thromb Vasc Biol; 2017 Aug 25; 37(8):1470-1481. PubMed ID: 28642237
    [Abstract] [Full Text] [Related]

  • 11. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A, Renga B, Distrutti E, Fiorucci S.
    Am J Physiol Heart Circ Physiol; 2009 Feb 25; 296(2):H272-81. PubMed ID: 19028791
    [Abstract] [Full Text] [Related]

  • 12. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
    Du F, Gesang Q, Cao J, Qian M, Ma L, Wu D, Yu H.
    Int J Mol Sci; 2016 Nov 18; 17(11):. PubMed ID: 27869741
    [Abstract] [Full Text] [Related]

  • 13. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
    Pendse AA, Johnson LA, Kim HS, McNair M, Nipp CT, Wilhelm C, Maeda N.
    Arterioscler Thromb Vasc Biol; 2012 Jun 18; 32(6):1436-44. PubMed ID: 22539598
    [Abstract] [Full Text] [Related]

  • 14. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L, Yang X, Li Q, Zeng P, Liu Y, Liu L, Chen Y, Yu M, Ma C, Li X, Li Y, Zhang R, Zhu Y, Miao QR, Han J, Duan Y.
    Arterioscler Thromb Vasc Biol; 2017 Jul 18; 37(7):1290-1300. PubMed ID: 28546220
    [Abstract] [Full Text] [Related]

  • 15. Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation.
    Fukuda K, Matsumura T, Senokuchi T, Ishii N, Kinoshita H, Yamada S, Murakami S, Nakao S, Motoshima H, Kondo T, Kukidome D, Kawasaki S, Kawada T, Nishikawa T, Araki E.
    Biochem Biophys Res Commun; 2015 Jan 30; 457(1):23-30. PubMed ID: 25529449
    [Abstract] [Full Text] [Related]

  • 16. Fat mass and obesity-associated protein attenuates lipid accumulation in macrophage foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice.
    Mo C, Yang M, Han X, Li J, Gao G, Tai H, Huang N, Xiao H.
    J Hypertens; 2017 Apr 30; 35(4):810-821. PubMed ID: 28253220
    [Abstract] [Full Text] [Related]

  • 17. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
    Lv YC, Yang J, Yao F, Xie W, Tang YY, Ouyang XP, He PP, Tan YL, Li L, Zhang M, Liu D, Cayabyab FS, Zheng XL, Tang CK.
    Atherosclerosis; 2015 May 30; 240(1):80-9. PubMed ID: 25765596
    [Abstract] [Full Text] [Related]

  • 18. Quercetin up-regulates expressions of peroxisome proliferator-activated receptor γ, liver X receptor α, and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage cell line.
    Lee SM, Moon J, Cho Y, Chung JH, Shin MJ.
    Nutr Res; 2013 Feb 30; 33(2):136-43. PubMed ID: 23399664
    [Abstract] [Full Text] [Related]

  • 19. Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux.
    Liu J, Wang Q, Wei Y, Zhang S, Chai E, Tang F.
    Microvasc Res; 2022 Mar 30; 140():104276. PubMed ID: 34742813
    [Abstract] [Full Text] [Related]

  • 20. Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2.
    Yin X, Polidano E, Faverdin C, Marche P.
    J Hypertens; 2005 Feb 30; 23(2):337-50. PubMed ID: 15662222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.